arrow
C

Christina Peters

st anna childrens hospital
H指数:73
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Total body irradiation versus chemotherapy before stem cell transplantation in children aged two to four with acute lymphoblastic leukemia—an EBMT pediatric diseases working party study

儿童急性淋巴细胞白血病2至4岁患者造血干细胞移植前全身照射与化疗的比较——EBMT儿科疾病工作组研究

Leukemia
IF13.4
2026-08-210
OA
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM trial

FORUM试验中微量残留病对儿童急性淋巴细胞白血病造血干细胞移植结局的影响

2026-01-011
OA
Blinatumomab consolidation in children with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia: final 5-year follow-up analysis of a randomized multicenter phase 3 study

Blinatumomab巩固治疗在具有高风险初发复发B细胞前体急性淋巴细胞白血病儿童中的疗效:一项随机多中心III期研究的最终5年随访分析

Leukemia
IF13.4
2025-11-130
PRE
Opportunities and Challenges with CAR T-cell Treatment of Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: Review and Recommendations from the Westhafen Intercontinental Group

CAR T细胞治疗儿童和年轻成人B细胞急性淋巴细胞白血病的机遇与挑战:Westhafen Intercontinental Group的综述与建议

2025-10-300
OAAI
Comparison of outcomes of BuCy versus BuCyMel as preparation for allogeneic HSCT in infants with acute myeloid leukemia in first complete remission: a multicenter study from the EBMT PDWP

比较BuCy与BuCyMel作为异基因HSCT预处理方案在首次完全缓解期婴儿急性髓系白血病中的疗效:一项来自EBMT PDWP的多中心研究

2025-10-280
PRE
Multinational retrospective analysis of bridging therapy prior to chimeric antigen receptor t cells for relapsed/refractory acute lymphoblastic leukemia in children and young adults

儿童和青年复发/难治性急性淋巴细胞白血病嵌合抗原受体t细胞前桥接治疗的跨国回顾性分析

2025-01-170
OA
Comparative Results of Pediatric Patients with ALL Receiving Either of Two Different Types of Human Anti-T Lymphocyte Globulin Prior to Hematopoietic Stem Cell Transplantation: Findings from the International Prospective Forum Study

比较接受两种不同类型人抗T淋巴细胞球蛋白的儿童急性淋巴细胞白血病(ALL)患者,在造血干细胞移植前的结果:国际前瞻性论坛研究的结果

BLOOD
IF23.1
2024-11-050
PRE
Prevalence of fungal DNAemia mediated by putatively non-pathogenic fungi in immunocompromised patients with febrile neutropenia: a prospective cohort study
2024-08-070
OAAI
Anti-T-lymphocyte globulin exposure is associated with acute graft- versus-host disease and relapse in pediatric acute lymphoblastic leukemia patients undergoing hematopoietic stem cell transplantation: amultinational prospective study
2024-05-090
OAAI
Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukemia in children and young adults
2024-02-151
OAAI
Low rate of nonrelapse mortality in under-4-year-olds with ALL given chemotherapeutic conditioning for HSCT: a phase 3 FORUM study
2024-01-122
OAAI
Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study
2024-01-045
OAAI
Evaluating the cost implications of integrating SARS-CoV-2 genome sequencing for infection prevention and control investigation of nosocomial transmission within hospitals
2023-09-012
OAAI
Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL
LEUKEMIA
IF13.4
2022-12-0812
OAAI
Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trial

前瞻性全SCT 2003试验的ALL长期随访儿童基于全身照射的同种异体HSCT后继发恶性肿瘤的发生率

LEUKEMIA
IF13.4
2022-09-1211
OAAI